Developmental disorders
Chapter C.5
Global concerns: Implications for the future
Child Mental Health Atlas
Mental Health Policy and Service Guidance Package
Languages: Arabic, English, French, Chinese, Russian
This content is from the Advance Chapters of the NEW Where There Is No Doctor. You can download this chapter in Bangla, English, Haitian Kreyol, Lao, Nepali, Spanish, and Swahili
This manual is both a guide to treatment and a workbook for persons who suffer from genalized anxiety disorder.
BMJ VOLUME 322 24 FEBRUARY 2001 bmj.com
Recognition, Assessment and Treatment
National Clinical Guideline Number 159
The purpose of the Clinical Practice Guideline for Treatment of Patients with Anxiety Disorders in Primary Care is to provide professionals with practical recommendations based on scientific evidence to assist in the detection and effective treatment of these disorders
Indian J Psychiatry. 2017 Jan; 59(Suppl 1): S67–S73.
doi: 10.4103/0019-5545.196975: 10.4103/0019-5545.196975
Research Paper, Accessed April 10,2019
https://www.researchgate.net/publication/47460246_Mental_illness-stigma_and_discrimination_in_Zambia
BMC Psychiatry 2014 14:191 https://doi.org/10.1186/1471-244X-14-191
Mortality and burden of disease attributable to selected major risks
Globally each year, millions of people suffer illness or lose their lives because the vaccines, medicines and diagnostic tests that they need are either unavailable or unaffordable – and this lack of access to medicine is acute in low- and middle-in-
come countries (LMICs). While the COVID-19 pan...demic laid this inequity bare, it also saw the pharmaceutical industry develop and bring new vaccines and treat- ments to market at unprecedented speed. As the world emerges from the worst
of this crisis, pharmaceutical companies are now at an important juncture, where lessons learned from the pandemic can prove pivotal in finding solutions to bridge long-standing gaps in access to medicine in LMICs.
more
The growing challenges for people in low and middle-income countries to access new medicines.
Analysis 58